Latest Financials News

Alterity Therapeutics has raised A$40 million through a two-tranche placement to advance its lead compound ATH434 for neurodegenerative diseases, including Multiple System Atrophy and Parkinson's disease.

Inventis Limited updates its operational review with corrected financials, securing major orders and pursuing significant capital raises to fuel international expansion.

Tasman Resources updates shareholders on Eden Innovations’ ongoing sale of a Georgia industrial property and the extension of its iBorrow financing facility, aiming to unlock value amid protracted negotiations.

Polymetals has raised $35 million through a share placement to fund the restart of its Endeavor silver and zinc mine and accelerate exploration efforts, positioning the company for production in Q2 2025.

WAM Global reports a robust 23.7% increase in its investment portfolio for the year ending December 2024, prompting a rise in fully franked dividends including a special payout. The company’s strong financial results underscore its confidence in sustained growth and shareholder returns.

Eden Innovations has agreed in principle to amend the sale contract for its Augusta, Georgia industrial property and secured an extension of its iBorrow financing facility until January 2026, pending final agreements.

Teaminvest Private Group Limited (TIP) reported a robust 21% rise in statutory NPAT for 1H25, alongside a 1.5 cent interim dividend and ongoing share buy-back, underscoring confidence in its undervalued shares.

Teaminvest Private Group Limited reported a 20.1% rise in half-year profit after tax, even as revenues slipped slightly by 0.9%. The company also declared a steady dividend, signaling confidence amid mixed financial signals.

8VI Holdings Limited has requested an immediate voluntary suspension of its securities on the ASX, paving the way for its planned delisting on 13 February 2025.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

WAM Global Limited has reported a remarkable 148.4% increase in revenue and a 182.3% rise in net profit for the half year ended December 31, 2024, underpinning a substantial hike in dividends.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.